Načítá se...
Advances in Sickle Cell Therapies in the Hydroxyurea Era
In the hydroxyurea era, insights into mechanisms downstream of erythrocyte sickling have led to new therapeutic approaches for patients with sickle cell disease (SCD). Therapies have been developed that target vascular adhesion, inflammation and hemolysis, including innovative biologics directed aga...
Uloženo v:
| Vydáno v: | Mol Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
ScholarOne
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4374518/ https://ncbi.nlm.nih.gov/pubmed/25549232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2014.00187 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|